$URGN raised $160m in Jan'19 at $41 per share through Goldman Sachs, J.P. Morgan, Jefferies &amp; Oppenheimer. Only progress and progress since then.

Deal with Agenus $AGEN
Working on BotoxGel with $AGN
Feasibility study ongoing with Janssen $JNJ

Trading at $21